Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-8p88z Total loading time: 0 Render date: 2026-11-19T11:32:00.228Z Has data issue: false hasContentIssue false

34 - Influenza

from Part I - Systems

Published online by Cambridge University Press:  15 December 2009

Asim A. Jani
Affiliation:
Assistant Director, Infectious Diseases Fellowship Program, Orlando Regional Healthcare, Orlando, FL
Timothy M. Uyeki
Affiliation:
Assistant Clinical Professor of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION

Influenza is an acute respiratory disease caused by influenza viruses transmitted primarily by droplets expelled during coughing and sneezing. Influenza type A and B virus infections can cause substantial human disease and mortality worldwide. Patients present with variable signs and symptoms depending on age and the presence of underlying chronic disease. Seasonal winter influenza epidemics in temperate countries can have a substantial impact on the emergency department (ED), but travelers may present with influenza illness acquired in other countries year-round. Rarely, the emergence of a novel influenza A subtype virus can lead to a global influenza pandemic.

Influenza viruses are single-stranded negative sense RNA viruses of the family Orthomyxoviridae. Three types (A, B, and C) of influenza viruses infect humans. Type A and B viruses are known to cause significant human disease. The genome contains eight gene segments that code for 11 proteins, including the two main surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). Type A viruses are further classified into subtypes based on their HA and NA proteins. Currently circulating human influenza A subtypes include A (H1N1) and A (H3N2) viruses. Human influenza viruses bind to and replicate primarily in epithelial cells of the upper respiratory tract.

Influenza viruses are evolving continuously through a process called “antigenic drift” in which random point mutations in the HA gene result in changes to the HA surface protein.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Influenza
    • By Asim A. Jani, Assistant Director, Infectious Diseases Fellowship Program, Orlando Regional Healthcare, Orlando, FL, Timothy M. Uyeki, Assistant Clinical Professor of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.035
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Influenza
    • By Asim A. Jani, Assistant Director, Infectious Diseases Fellowship Program, Orlando Regional Healthcare, Orlando, FL, Timothy M. Uyeki, Assistant Clinical Professor of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.035
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Influenza
    • By Asim A. Jani, Assistant Director, Infectious Diseases Fellowship Program, Orlando Regional Healthcare, Orlando, FL, Timothy M. Uyeki, Assistant Clinical Professor of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.035
Available formats
×